Reply to the letter regarding "Palliative care and end-of-life care in adults with malignant brain tumors"

Johan A F Koekkoek^{1

2}, Pim B van der Meer¹, Tobias Walbert³

Affiliations

¹ Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
² Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
³ Department of Neurology and Neurosurgery, Henry Ford Health System and Department of Neurology Wayne State University, Detroit, Michigan,USA.

Editorial

Johan A F Koekkoek et al. Neuro Oncol. 2023.

. 2023 Jul 6;25(7):1377-1378.

doi: 10.1093/neuonc/noad069.

Johan A F Koekkoek^{1

2}, Pim B van der Meer¹, Tobias Walbert³

¹ Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
² Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
³ Department of Neurology and Neurosurgery, Henry Ford Health System and Department of Neurology Wayne State University, Detroit, Michigan,USA.

No abstract available

Conflict of interest statement

None of the authors declare a conflict of interest.

Palliative care and end-of-life care in adults with malignant brain tumors.
Koekkoek JAF, van der Meer PB, Pace A, Hertler C, Harrison R, Leeper HE, Forst DA, Jalali R, Oliver K, Philip J, Taphoorn MJB, Dirven L, Walbert T. Koekkoek JAF, et al. Neuro Oncol. 2023 Mar 14;25(3):447-456. doi: 10.1093/neuonc/noac216. Neuro Oncol. 2023. PMID: 36271873 Free PMC article.
Letter regarding "Palliative care and end-of-life care in adults with malignant brain tumors".
Röttgering JG, Klein M, Douw L. Röttgering JG, et al. Neuro Oncol. 2023 Mar 14;25(3):612-613. doi: 10.1093/neuonc/noad006. Neuro Oncol. 2023. PMID: 36801954 Free PMC article. No abstract available.

1. Röttgering JG, Klein M, Douw L.. Letter regarding “Palliative care and end-of-life care in adults with malignant brain tumors.”. Neuro Oncol. 2023;25(3):612–613. - PMC - PubMed
1. de Rooij BH, Oerlemans S, van Deun K, et al. . Symptom clusters in 1330 survivors of 7 cancer types from the PROFILES registry: A network analysis. Cancer. 2021;127(24):4665–4674. - PMC - PubMed
1. Coomans MB, Dirven L, Aaronson NK, et al. . Symptom clusters in newly diagnosed glioma patients: Which symptom clusters are independently associated with functioning and global health status? Neuro Oncol. 2019;21(11):1447–1457. - PMC - PubMed
1. Marson A, Burnside G, Appleton R, et al. ; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: An open-label, non-inferiority, multicentre, phase 4, randomized controlled trial. Lancet. 2021;397(10282):1375–1386. - PMC - PubMed
1. Van der Meer PB, Dirven L, Fiocco M, et al. . First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid. Epilepsia. 2021;62(5):1119–1129. - PMC - PubMed